ripekg:evaluation/RIPEA148131811A593CED |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
prov:startedAtTime |
2025-10-31T12:00:22.178257Z |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA148131811A593CED |
ripekg:publication-details/RIPEA148131811A593CEDPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
ripekg:registry-evidence/RIPEA148131811A593CED |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA148131811A593CED |
ripekg:study-design-evidence/RIPEA148131811A593CED |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA148131811A593CED |